Skip to main content

Bypass Patients Should Continue Statin Treatment

A new review of 21 studies challenges the conventional wisdom that it’s preferable to discontinue statins before and after coronary bypass surgery.

Republish
Texas Tribune Events: The New Med Ed

A new review of 21 studies challenges the conventional wisdom that it’s preferable to discontinue statins before and after coronary bypass surgery. The review found that continuing statins reduced complications and lowered the chances of death. (The New York Times)

Texans need truth. Help us report it.

Independent Texas reporting needs your support. The Texas Tribune delivers fact-based journalism for Texans, by Texans — and our community of members, the readers who donate, make our work possible. Help us bring you and millions of others in-depth news and information. Will you support our nonprofit newsroom with a donation of any amount?

Support independent Texas news

Become a member. Join today.

Choose an amount or learn more about membership.

$20 $25 $50 Other
Donate now

Information about the authors

Jacob Sanchez’s staff photo

Learn about The Texas Tribune’s policies, including our partnership with The Trust Project to increase transparency in news.

Explore related story topics